Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/108908) titled 'A Study to Compare Different Oral Iron Supplements in Healthy Adults' on April 21.
Study Type: Interventional
Study Design:
Randomized, Crossover Trial Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label
Primary Sponsor: Taiyo Kagaku India Pvt. Ltd.
Intervention:
Intervention1: Iron Variant T1: One tablet containing ferric pyrophosphate equivalent to 27 mg elemental iron administered orally as a single dose.
Intervention2: Iron Variant T2: One mL liquid formulation containing ferric pyrophosphate equivalent to 27 mg e...